Suppr超能文献

基于肠道菌群探讨培元开郁方在脑小血管病中的抗抑郁作用

The anti-depressive role of the Pei Yuan Kai Yu formula in cerebral small vessel disease based on gut microbiota.

作者信息

Yang Lixuan, Ao Yutian, Li Yannan, Dai Baoan, Li Junnan, Duan Wenzhe, Dong Kaiqiang, Han Zhenyun, Guo Rongjuan

机构信息

Department of Neurology, Beijing University of Chinese Medicine, Beijing, China.

Department of Neurology, Beijing Fengtai District Hospital of Traditional Chinese Medicine, Beijing, China.

出版信息

Front Pharmacol. 2025 Jun 13;16:1510250. doi: 10.3389/fphar.2025.1510250. eCollection 2025.

Abstract

BACKGROUND

Cerebral small vessel disease (CSVD), characterized by pathological changes in brain vessels, is a common cause of death in the elderly and often accompanied by depression, which significantly affects patients' quality of life and rehabilitation; understanding its pathogenesis and developing innovative therapies are urgently needed, especially considering the role of the blood - brain barrier impairment and the gut - microbiota - gut - brain axis in this complex condition.

METHODS

Dahl/SS rats were fed a diet containing 8% NaCl and were subjected to chronic unpredictable mild stress (CUMS) stimulation for 4 weeks. PY (1.407 g/kg/day) was administered intragastrically to evaluate its role in CSVD with depression. Pseudo germ-free rats were colonized with gut microbiota from high-salt-fed rats exposed to CUMS, followed by PY administration.

RESULTS

In rats with CSVD and depression, PY significantly increased body weight; alleviated depression-like behaviors; and decreased the levels of inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in both serum and hippocampus. Additionally, PY reversed inflammation-induced nerve damage; reduced the overexpression of microglia in the hippocampus; decreased the levels of hippocampal VEGF and MMP-9, and increased the levels of hippocampal occludin, ZO-1, and claudin-5. Moreover, PY improved the composition of gut microbiota and enhanced microbial diversity. PY induced characteristic changes in the microbiome, which were associated with inflammation, endothelial dysfunction, and depressive-like behaviors. These significant metabolites were identified and were found closely related to inflammation, endothelial cell dysfunction, and depression-like behaviors.

CONCLUSION

In conclusion, PY acts as an antidepressant to slow down the progression of CSVD by inhibiting microglial activation, reducing inflammation and ameliorating endothelial dysfunction. It exerts its effect, at least in part, by enhancing microbiota-mediated metabolism .

摘要

背景

脑小血管疾病(CSVD)以脑血管病理改变为特征,是老年人常见的死亡原因,常伴有抑郁症,严重影响患者的生活质量和康复;迫切需要了解其发病机制并开发创新疗法,尤其是考虑到血脑屏障损伤和肠道微生物群-肠-脑轴在这种复杂病症中的作用。

方法

给 Dahl/SS 大鼠喂食含 8%氯化钠的饮食,并进行 4 周的慢性不可预测轻度应激(CUMS)刺激。通过灌胃给予 PY(1.407 g/kg/天)以评估其在伴有抑郁症的 CSVD 中的作用。将无菌大鼠用来自暴露于 CUMS 的高盐喂养大鼠的肠道微生物群进行定殖,然后给予 PY。

结果

在患有 CSVD 和抑郁症的大鼠中,PY 显著增加体重;减轻抑郁样行为;降低血清和海马中 TNF-α、IL-1β 和 IL-6 等炎症细胞因子的水平。此外,PY 逆转了炎症诱导的神经损伤;减少海马中微胶质细胞的过度表达;降低海马 VEGF 和 MMP-9 的水平,并增加海马闭合蛋白、ZO-1 和 Claudin-5 的水平。此外,PY 改善了肠道微生物群的组成并增强了微生物多样性。PY 诱导了微生物组的特征性变化,这些变化与炎症、内皮功能障碍和抑郁样行为有关。鉴定出这些重要代谢产物,并发现它们与炎症、内皮细胞功能障碍和抑郁样行为密切相关。

结论

总之,PY 作为一种抗抑郁药,通过抑制小胶质细胞活化、减轻炎症和改善内皮功能障碍来减缓 CSVD 的进展。它至少部分地通过增强微生物群介导的代谢发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7814/12202353/ea15a2e78928/fphar-16-1510250-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验